Refine
Document Type
- Article (5)
- Doctoral Thesis (3)
Has Fulltext
- yes (8)
Is part of the Bibliography
- no (8)
Keywords
- metabolism (8) (remove)
Institute
- Institut für Mikrobiologie - Abteilung für Genetik & Biochemie (3)
- Abteilung für Mikrobiologie und Molekularbiologie (1)
- Institut für Klinische Chemie und Laboratoriumsmedizin (1)
- Institut für Pharmazie (1)
- Interfakultäres Institut für Genetik und Funktionelle Genomforschung (MNF) (1)
- Universitätsmedizin (1)
Publisher
- Frontiers Media S.A. (2)
- MDPI (1)
- SAGE Publications (1)
- Wiley (1)
Flupirtine and retigabine were essential drugs to combat pain and epilepsy. However, the Kv7 potassium channel openers are fraught with hepatotoxicity and tissue discoloration, respectively, limiting their therapeutic value. Both adverse events are likely due to reactive metabolites arising from oxidative metabolism. Designing safer analogues lacking the structural elements leading to described side effects is an active area of current research. One of the main metabolites of flupirtine is the biologically inactive 4-fluorohippuric acid. Hitherto unexplained, the proposed metabolic pathway leading to the formation of 4-fluorohippuric acid from flupirtine is verified here. Through the use of eighteen flupirtine analogues, mechanistic details of this pathway could be elucidated. A possible connection with the in vitro hepatotoxicity of the flupirtine analogues and the levels of 4-fluorobenzoic acid formed in enzyme incubations was examined by correlation analysis. These findings provide important information for the design of new flupirtine analogues as potential drug candidates.